National trends in out-of-pocket prescription drug spending among elderly medicare beneficiaries

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 5, Issue 3, 2005, Pages 297-315

  Sambamoorthi, Usha ^a,b,c   Akincigil, Ayse ^a   Wei, Wenhui ^a   Crystal, Stephen ^a  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Drug; Elderly; Medicare; Medicare current beneficiary survey; National

Indexed keywords

DRUG;

CHRONIC DISEASE; COST BENEFIT ANALYSIS; COST CONTROL; DRUG COST; DRUG UTILIZATION; ECONOMIC ASPECT; ELDERLY CARE; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE PLANNING; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; HEALTH STATUS; HUMAN; MEDICAID; MEDICARE; PHARMACEUTICAL CARE; POVERTY; PRESCRIPTION; REVIEW; SOCIOECONOMICS;

EID: 21244479029     PISSN: 14737167     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737167.5.3.297     Document Type: Review

References (59)

1. Thomas CP, Ritter G, Wallack SS. Growth in prescription drug spending among insured elders. Health Aff. (Millwood) 20(5), 265-277 (2001).
2. Morgan SG. Quantifying components of drug expenditure inflation: the British Columbia seniors' drug benefit plan. Health Serv. Res. 37(5), 1243-1266 (2002).
3. Martin BC, Miller LS, Kotzan JA. Antipsychotic prescription use and costs for persons with schizophrenia in the 1990s: current trends and five year time series forecasts. Schizophr. Res. 47(2-3), 281-292 (2001).
4. Lund BC, Flaum M, Adam LA, Perry PJ. Psychiatric prescribing trends and practices in Iowa's prisons. Psychiatr. Serv. 53(8), 1023-1024 (2002).
5. Halbert RJ, Zaher C, Wade S et al. Out-patient cancer drug costs: changes, drivers, and the future. Cancer 94(4), 1142-1150 (2002).
6. Dubois RW, Chawla AJ, Neslusan CA, Smith MW, Wade S. Explaining drug spending trends: does perception match reality? Health Aff. (Millwood) 19(2), 231-239 (2000).
7. Copeland C. Prescription drugs: issues of cost, coverage, and quality. EBRI Issue Brief 208, 1-21 (1999).
8. Baugh DK, Pine PL, Blackwell S. Trends in Medicaid prescription drug utilization and payments, 1990-97. Health Care Financ. Rev. 20(3), 79-105 (1999).
9. Suh DC, Lacy CR, Barone JA, Moylan D, Kostis JB. Factors contributing to trends in prescription drug expenditures. Clin. Ther. 21(7), 1241-1253 (1999).
10. Fink KS, Byrns PJ. Changing prescribing patterns and increasing prescription expenditures in Medicaid. Ann. Fam. Med 2(5), 488-493 (2004).
11. Kreling D, Mott D, Wiederholt J, Lundy J, Levitt L. In: Prescription Drug Chartbook: An Update. Kaiser Family Foundation, CA, USA (2001).
12. Anderson GM, Kerluke KJ, Pulcins IR, Hertzman C, Barer ML. Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program. Inquiry 30(2), 199-207 (1993).
13. Morgan S. Drug spending in Canada: recent trends and causes. Med. Care 42(7), 635-642 (2004).
14. Mueller C, Schur C, O'Connell J. Prescription drug spending: the impact of age and chronic disease status. Am. J. Public Health 87(10), 1626-1629 (1997).
15. Steinberg EP, Gutierrez B, Momani A et al. Beyond survey data: a claims-based analysis of drug use and spending by the elderly. Health Aff. (Millwood) 19(2), 198-211 (2000).
16. Poisal JA, Murray L. Growing differences between Medicare beneficiaries with and without drug coverage. Health Aff. (Millwood) 20(2), 74-85 (2001).
17. Cunningham PJ. Prescription drug access: not just a Medicare problem. Issue Brief Cent. Stud. Health Syst. Change 51, 1-4 (2002).
18. Crystal S, Johnson RW, Harman J, Sambamoorthi U, Kumar R. Out-of-pocket healthcare costs among older Americans. J. Gerontol. B. Psychol. Sci. Soc. Sci. 55(1), S51-S62 (2000).
19. Sambamoorthi U, Shea D, Crystal S. Total and out-of-pocket expenditures for prescription drugs among older persons. Gerontologist 43(3), 345-359 (2003).
20. Goldman DP, Zissimopoulos JM. High out-of-pocket healthcare spending by the elderly. Health Aff. (Millwood) 22(3), 194-202 (2003).
21. McKercher PL, Taylor SD, Lee JA, Chao J, Kumar RN. Prescription drug use among elderly and nonelderly families. J. Manag. Care Pharm. 9(1), 19-28 (2003).
22. Briesacher B, Stuart B, Shea D. Drug coverage for Medicare beneficiaries: why protection may be in jeopardy. Issue Brief (Commonw. Fund) 505, 1-8 (2002).
23. Federman AD, Adams AS, Ross-Degnan D, Soumerai SB, Ayanian JZ. Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease. JAMA 286(14), 1732-1739 (2001).
24. Rogowski J, Lillard LA, Kington R. The financial burden of prescription drug use among elderly persons. Gerontologist 37(4), 475-482 (1997).
25. Lillard LA, Rogowski J, Kington R. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population. Med. Care 37(9), 926-936 (1999).
26. Atherly A. The effect of Medicare supplemental insurance on Medicare expenditures. Int. J. Health Care Finance Econ. 2(2), 137-162 (2002).
27. Andrade SE, Gurwitz JH. Drug benefit plans under managed care: to what extent do older subscribers selecting less drug coverage put themselves at increased financial risk? J. Am. Geriatr Soc. 50(1), 178-181 (2002).
28. Adams AS, Soumerai SB, Ross-Degnan D. The case for a medicare drug coverage benefit: a critical review of the empirical evidence. Annu. Rev. Public Health 22, 49-61 (2001).
29. Poisal JA, Chulis GS. Medicare beneficiaries and drug coverage. Health Aff. (Millwood) 19(2), 248-256 (2000).
30. Poisal JA. Reporting of drug expenditures in the MCBS. Health Care Financ. Rev. 25(2), 23-36 (2003).
31. Laschober MA, Kitchman M, Neuman P, Strabic AA. Trends in Medicare supplemental insurance and prescription drug coverage, 1996-1999. Health Aff. (Millwood) (Suppl.), W127-W138 (2002).
32. Gross DJ, Alecxih L, Gibson MJ et al. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries. Health Serv. Res. 34(1 Pt 2), 241-254 (1999).
33. Blendon RJ, Schoen C, DesRoches C, Osborn R, Zapert K. Common concerns amid diverse systems: healthcare experiences in five countries. Health Aff. (Millwood) 22(3), 106-121 (2003).
34. Goldman DP, Smith JP. Methodological biases in estimating the burden of out-of-pocket expenses. Health Serv. Res. 35(6), 1357-1365; discussion 1365-1370 (2001).
35. Alecxih L, Corea J, Gross D et al. Reply: methodological biases in estimating the burden of out-of-pocket expenses. Health Serv. Res. 35(6), 1365-1370 (2001).
36. Davis M, Poisal J, Chulis G, Zarabozo C, Cooper B. Prescription drug coverage, utilization, and spending among Medicare beneficiaries. Health Aff. (Millwood) 18(1), 231-243 (1999).
37. Margo L, Rosenbach ML, Lamphere J. Bridging the Gaps Between Medicare and Medicaid: The Case of QMBs and SLMBs. Mathematica Policy Research, Inc. and AARP (1999).
38. Chu SY, Barker LE, Smith PJ. Racial/ethnic disparities in preschool immunizations: United States, 1996-200 1. Am. J. Public Health 94(6), 973-977 (2004).
39. Finlayson SR, Stroupe KT, Joseph GJ, Fisher ES. Using the Veterans Health Administration in-patient care database: trends in the use of antireflux surgery. Eff. Clin. Pract. 5(3 Suppl.), E5 (2002).
40. Goff DC Jr, Howard G, Wang CH et al. Trends in severity of hospitalized myocardial infarction: the atherosclerosis risk in communities (ARIC) study, 1987-1994. Am. Heart J. 139(5), 874-880 (2000).
41. Diehr P, Yanez D, Ash A, Hornbrook M, Lin DY. Methods for analyzing healthcare utilization and costs. Ann. Rev. Public Health 20, 125-144 (1999).
42. Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J. Health Econ. 17(3), 283-295 (1998).
43. Halvorsen R, Palmquist R. The Interpretation of dummy variables in semilogarithmic equations. Amer. Econ. Rev. 70(3), 474-475 (1980).
44. StataCorp, Stata Statistical Software. Stata Corporation: College Station, TX, USA (2004).
45. Curtis LH, Law AW, Anstrom KJ, Schulman KA. The insurance effect on prescription drug expenditures among the elderly: findings from the 1997 Medical Expenditure Panel Survey. Med. Care 42(5), 439-446 (2004).
46. Gianfrancesco FD, Baines AP, Richards D. Utilization effects of prescription drug benefits in an aging population. Health Care Financ. Rev. 15(3), 113 (1994).
47. Goldman DP, Leibowitz AA, Joyce GF et al. Insurance status of HIV-infected adults in the post-HAART era: evidence from the United States. Appl. Health Econ. Health Policy 2(2), 85-90 (2003).
48. Gross D, Brangan N. Out-of-pocket spending on healthcare by Medicare beneficiaries age 65 and older: 1999 projections. Issue Brief (Public Policy Inst. [Am. Assoc. Retired Pers.]) IB41, 1-14 (1999).
49. Johnson RW, Sambamoorthi U, Crystal S. Gender differences in pension wealth: estimates using provider data. Gerontologist 39(3), 320-333 (1999).
50. Hurd MD, McGarry K. Medical insurance and the use of healthcare services by the elderly. J. Health Econ. 16(2), 129-154 (1997).
51. Kaiser Family Foundation. How the Medicare HMO Withdrawals Affect Beneficiary Benefits, Costs, and Continuity of Care. The Henry J. Kaiser Foundation, Menlo Park, CA, USA (1999).
52. Shea DG, Russo PA, Smyer MA. Use of mental health services by persons with a mental illness in nursing facilities: initial impacts of OBRA87. J. Aging Health 12(4), 560-578 (2000).
53. Mulligan K. Access to drugs questionable for medicaid patients under new law. Psychiatr News 39(2), 1a50 (2004).
54. Stuart B, Ahern F, Rabatin V, Johnson A. Patterns of out-patient prescription drug use among Pennsylvania elderly. Health Care Financ. Rev. 12(3), 61-72 (1991).
55. Lassila HC, Stoehr GP, Ganguli M et al. Use of prescription medications in an elderly rural population: the MoVIES Project. Ann. Pharmacother. 30(6), 589-595 (1996).
56. BoccutiC, Moon M, Dowling K. Chronic conditions and disabilities: trends and issues for private drug plans. Policy Brief Commonw. Fund 680, 1-10 (2003).
57. Berk ML, Schur CL, Mohr P. Using survey data to estimate prescription drug costs. Health Aff. (Millwood) 9(3), 146-156 (1990).
58. Moeller JF, Mathiowetz NA. Correcting errors in prescription drug reporting: a critique. Health Aff. (Millwood) 10(1), 210-214 (1991).
59. Eppig FJ Jr, Poisal JA. Medicare beneficiary's use of prescription drug discount cards, CY 2002. Health Care Financ. Rev. 25(2), 91-94 (2003).